Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns

References

• Roca I, Espinal P, Vila-Farres X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol 2012;3:1–30.
   PubMedGoogle Scholar
• de Breij A. Towards an explanation for the success of Acinetobacter baumannii in the human host. Leiden, Netherland: Faculty of Medicine Leiden University; 2012.
   Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538–82.
   PubMed Web of Science ®Google Scholar
• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007;51:3471–84.
   PubMed Web of Science ®Google Scholar
• de Breij A, Haisma E, Rietveld M, El Ghalbzouri A, van den Broek P, Dijkshoorn L, et al. Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization. Antimicrob Agents Chemother 2012;56:2459–64.
   PubMedGoogle Scholar
• Perez F, Ponce-Terashima R, Adams MD, Bonomo RA. Are we closing in on an “elusive enemy”? The current status of our battle with Acinetobacter baumannii. Virulence 2011; 2:86–90.
   PubMed Web of Science ®Google Scholar
• Espinal P, Marti S, Vila J. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 2012;80:56–60.
   PubMed Web of Science ®Google Scholar
• Marti S, Rodriguez-Bano J, Catel-Ferreira M, Jouenne T, Vila J, Seifert H, et al. Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res Notes 2011;4:5.
   PubMedGoogle Scholar
• De Breij A, Dijkshoorn L, Lagendijk E, van der Meer J, Koster A, Bloemberg G, et al. Do biofilm formation and interactions with human cells explain the clinical success of Acinetobacter baumannii? PloS One 2010;5:e10732.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. Biofilm: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167–93.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros JM, Pachon J, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008;14:276–8.
   PubMed Web of Science ®Google Scholar
• Goić-Barišić I, Bedenić B, Tonkić M, Katić S, Kalenić S, Punda-Polić V. First report of molecular characterization of carbapenem-resistant Acinetobacter baumannii in different intensive care units in University hospital Split, Croatia. J Chemother 2007;19:416–18.
   Google Scholar
• Goić-Barišić I, Bedenić B, Tonkić M, Novak A, Katić S, Kalenić S, et al. Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia. J Clin Microbiol 2009;47:3348–9.
   PubMed Web of Science ®Google Scholar
• Goić-Barišić I, Towner KJ, Kovačić A, Šiško-Kraljević, Tonkić M, Novak A, et al. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J Hosp Infect 2011; 77:368–9.
   PubMed Web of Science ®Google Scholar
• Goić-Barišić I, Kaliterna V. Multidrug-resistant Acinetobacter baumannii – the pathogen with no borders? Med Glas (Zenica) 2011;8:312–13.
   PubMed Web of Science ®Google Scholar
• Franolić-Kukina I, Bedenic B, Budimir A, Herljević Z, Vraneš J, Higgins PG. Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital. Int J Inf Dis 2011;15:706–9.
   PubMed Web of Science ®Google Scholar
• Croatian Committee for Antibiotic Resistance Surveillance. Antibiotic resistance in Croatia in 2008. Zagreb: Croatian Academy of Medical Sciences(CAMS); 2008.
   Google Scholar
• Croatian Committee for Antibiotic Resistance Surveillance. Antibiotic resistance in Croatia in 2013. Zagreb: Croatian Academy of Medical Sciences(CAMS); 2014.
   Google Scholar
• Evans BA, Hamouda A, Towner KJ, Amyes SGB. OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infect 2008;14:268–75.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests – Approved standard (M2-A9), 17th informational supplement. CLSI document M100-S17. Wayne, PA: CLSI; 2007.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters, version 1.1, 2010. Available from: http://www.eucast.org/clinical_breakpoints
   Google Scholar
• Seifert H, Dolzani L, Bressan R, van der Reijden, van Strijen B, Stefanik D, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005;43:4328–35.
   PubMed Web of Science ®Google Scholar
• PFGE typing protocol recommended by ARPAC for Acinetobacter baumannii. Available from: www.abdn.ac.uk/arpac/
   Google Scholar
• Schleicher X, Higgins PG, Wisplinghoff H, Korber-Irrgang B, Kresken M, Seifert H. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009). Clin Microbiol Infect 2013;19:737–42.
   PubMed Web of Science ®Google Scholar
• Rajamohan G, Srinivasan VB, Gebreyes WA. Biocide-tolerant multidrug-resistant Acinetobacter baumannii clinical strains are associated with higher biofilm formation. J Hosp Infect 2009;73:287–9.
   PubMedGoogle Scholar
• Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol 2008;26:333–7.
   PubMed Web of Science ®Google Scholar
• Wroblewska MM, Sawicka-Grzelak A, Marchel H, Luczak M, Sivian A. Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals. FEMS Immunol Med Microbiol 2008;53:140–4.
   PubMedGoogle Scholar
• Kaliterna V, Goić-Barišić I. The ability of biofilm formation in clinical isolates of Acinetobacter baumannii belonging to two different European clones causing outbreaks in the Split University Hospital, Croatia. J Chemother 2013;25:60–2.
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008;358:1271– 81.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Bano J, Cisneros JM, Fernandez-Cuenca F, Ribera A, Vila J, Pascual A, et al. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals. Infect Control Hosp Epidemiol 2004;25:819–24.
   PubMed Web of Science ®Google Scholar
• Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010;65:233–8.
   PubMed Web of Science ®Google Scholar
• Nemec A, Krizova L, Maixnerova M, Diancourt L, van der Reijden TJK, Berisse S, et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 2008; 62:484–9.
   PubMedGoogle Scholar
• Longo B, Pantosi A, Luzzi I, Tarasi A, Di Sora F, Gallo S, et al. Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit. Ann Ist Super Sanita 2007;43:83–8.
   PubMedGoogle Scholar
• Gogou V, Pournaras S, Giannouli M, Voulgari E, Piperaki ET, Zarrilli R, et al. Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). J Antimicrob Chemother 2011;66: 2767–72.
   PubMed Web of Science ®Google Scholar
• Lee HW, Koh YM, Kim J, Lee JC, Lee YC, Seol SY, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 2008;14: 49–54.
   PubMed Web of Science ®Google Scholar
• Davey ME, O'toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 2000;64: 847–67.
   PubMed Web of Science ®Google Scholar
• Perez LR. Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J Chemother 2015;27:13–16.
   PubMed Web of Science ®Google Scholar
• Nait Chabane Y, Mlouka MB, Alexandre S, Nicol M, Marti S, Pestel-Caron M, et al. Virstatin inhibits biofilm formation and motility of Acinetobacter baumannii. BMC Microbiol 2014;14:62.
   PubMedGoogle Scholar
• Sambanthamoorthy K, Feng X, Patel R, Patel S, Paranavitana C. Antimicrobial and antibiofilm potential of biosurfactants isolated from lactobacilli against multi-drug-resistant pathogens. BMC Microbiol 2014;14:197.
   PubMed Web of Science ®Google Scholar